Acute Gout Flare
Investigational use for acute monoarticular gout when NSAIDs and colchicine are contraindicated; evidence limited to a few small Ayurvedic pilot studies.
Patient Summary
- Is this FDA-cleared for this use?
- Not FDA-cleared for acute gout. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is investigational.
- What evidence exists?
- Only a few small pilot studies of leech therapy in acute gout have been published, mostly in Ayurvedic journals; one controlled pilot (2012) was non-randomized and included 22 patients. Tier C (investigational). Evidence-based first-line acute-flare therapy per ACR 2020 includes oral or intra-articular corticosteroids (NNT around 2), NSAIDs (where not contraindicated), and oral colchicine within 36 hours of flare onset. Long-term urate-lowering therapy (allopurinol, febuxostat) with target serum urate under 6 mg/dL prevents recurrent flares and tophus formation. Leech therapy does not address the underlying urate burden.
- Main risks
- Bleeding from bite sites for 6 to 24 hours after detachment, magnified if NSAIDs are also used
- Local skin infection or, rarely, Aeromonas infection in a tense, inflamed joint area
- Bruising and tenderness for 5 to 10 days
- Worsening of acute joint pain in the first 24 hours
- Allergic reaction to leech saliva (uncommon)
- Small bite marks that usually fade over weeks to months (rarely a pale spot stays longer)
- Misdiagnosis of septic arthritis as gout (joint aspiration must be considered)
- Delay of urate-lowering therapy with continued flare recurrence and tophus accumulation
- Who should not consider this
- Patients with septic arthritis (must be ruled out by joint aspiration if any doubt)
- Patients with tophus rupture and active discharge
- Patients on anticoagulants, with hemophilia, or with anemia
- Patients with active infection or sepsis
- Patients who can tolerate first-line therapy (corticosteroids, NSAIDs, colchicine)
- Patients who have not had a serum urate measured or do not have urate-lowering therapy in place
- What to ask your clinician
- Has septic arthritis been ruled out by joint aspiration (especially if monoarthritis, fever, recent procedures)?
- What is my serum urate, and am I on urate-lowering therapy (allopurinol, febuxostat) at goal under 6 mg/dL?
- Have I tried oral or intra-articular corticosteroid, or low-dose colchicine, for this flare?
- Why is leech therapy being offered when first-line therapy is well-tolerated?
- Where exactly will leeches be placed — around but not directly on the inflamed joint?
- What is the practitioner's experience and Aeromonas-prevention plan?
- What is my long-term flare-prevention plan?
- When to seek urgent care
- Hot swollen joint with high fever, chills, or feeling systemically unwell (possible septic arthritis — call clinician immediately)
- Inability to bear weight or use the joint
- Rapidly spreading redness up the limb (cellulitis or lymphangitis)
- Bleeding from a bite site lasting more than 24 to 48 hours
- Severe nausea, vomiting, or diarrhea (colchicine toxicity if taking)
- Severe joint pain unresponsive to first-line therapy
- Hives, throat tightness, or breathing difficulty
What this does NOT mean
- This is not FDA-cleared for acute gout.
- Small pilot and comparative studies do NOT establish efficacy versus oral corticosteroids, NSAIDs, or colchicine; the only comparison with a conventional drug that was identified used topical diclofenac gel.
- Mechanism rationale (anti-inflammatory peptides) does NOT lower serum urate or prevent future flares.
- Leech therapy is not a substitute for evidence-based acute-flare therapy or for urate-lowering medications.
- Septic arthritis can look like gout — joint aspiration should be considered before any non-standard therapy.
Safety cross-references
Clinical Profile
- Category
- Musculoskeletal
- ICD-10
- M10.00, M10.071, M10.072, M10.30
- Safety tier
- Medium
Evidence Summary
Clinical evidence is limited to a few small Ayurvedic studies published outside PubMed: a non-randomized controlled pilot of 22 patients comparing leeches with topical diclofenac gel (Panda and Debnath 2012), a 10-patient single-arm pilot (Jha and Londhe 2014), a 40-patient randomized comparison of leeches with venesection that had no non-bloodletting control (Rajeshwari 2020), and a 30-patient comparison of leeches plus an herbal decoction versus the decoction alone, in which serum uric acid did not change significantly (Bilonia and Kumar 2025). All are small and none has been independently replicated, so they do not establish that leech therapy reduces pain or flares in gout. The book by Michalsen et al. 2007 names gout as a main indication for leeching in the older literature but gives no study data or patient numbers for gout, and notes that modern clinical studies in arthritis are lacking (see “What the books describe” below). Any proposed anti-inflammatory or decongestive mechanism is speculative and unproven. First-line therapy for acute gout (NSAIDs, colchicine, and oral or intra-articular corticosteroids) and urate-lowering therapy for long-term prevention (allopurinol, febuxostat) remain essential. ASH position: any use of leech therapy for gout is investigational, rests on small low-quality pilot data, and should never displace effective standard treatment.
What the books describe
Below is a summary of what books on hirudotherapy say about this condition. These are the authors’ observations, not a proven effect and not a promise of results. Hirudotherapy has contraindications; the decision is made by a physician.
- Baskova and Isakhanyan do not write about gout: among the indications for hirudotherapy they name only “arthritis, polyarthritis, arthrosis” in general[B1].
- They retell an observation by Starodubskaya (1998): in inflammatory diseases of the joints, leeches placed on the affected joint had, according to her, a pain-relieving and anti-inflammatory effect; which joint diseases exactly are meant, how many patients there were and whether there was a comparison group is not clear from the text, and gout is not named[B1].
- Michalsen (chapter on scientific foundations) writes that gout (arthritis urica) is one of the main indications for hirudotherapy given in the older literature, and that historically leeches were used mainly for gout and for purulent infectious joint diseases[B3].
- Flecken and Michalsen (chapter on indications) call leech treatment an effective method for arthrosis of the first metatarsophalangeal joint (the base of the big toe) and for gout (in the book, podagra), but give no studies or numbers of patients for gout[B3].
- In the same place, in the chapter on scientific foundations, Michalsen writes that Bottenberg described a number of successfully treated cases, but in those days ibuprofen and allopurinol, which have now become the standard treatment, were not yet available; modern clinical studies of the efficacy of leeches in arthritis are, in his words, lacking, so leeches should be reserved for chronic cases and cases that do not respond to other treatment[B3].
- Michalsen advises against applying leeches directly to joints with acute inflammation, but allows an attempt in the intermediate stage, once the acute inflammation has subsided; this advice is in a paragraph devoted mainly to chronic polyarthritis and rheumatoid arthritis, and whether it applies directly to an attack of gout is not clear from the text[B3].
- Baskova and Isakhanyan, as well as Flecken and Michalsen (chapter on contraindications), list hemophilia and concurrent use of anticoagulants among the contraindications[B1][B3].
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)
Contraindications
- Hemophilia or another bleeding disorder
- Taking anticoagulants (blood thinners such as warfarin or heparin)
- Anemia or suppressed blood formation
- Low blood pressure, shock, collapse or fainting
- Severe wasting (cachexia)
- Intolerance of leeches or a history of severe allergic reactions
- Pregnancy
- Stomach or duodenal ulcer, erosive gastritis
- Acute infectious disease or high fever
- Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
- Drinking alcohol at the time of treatment
- No consent from the patient
- Septic arthritis (must rule out by joint aspiration if doubt)
- Tophus rupture with active discharge
Related Conditions
Knee Osteoarthritis
Off-label use; several small RCTs in knee OA report pain and function improvement with leeches versus NSAID gel, sham leech or TENS, though results against sham and TENS are mixed, and a 2022 trial against physiotherapy found no therapeutic effect.
Rheumatoid Arthritis
No published clinical study of leech therapy in rheumatoid arthritis was identified; early disease-modifying treatment remains the standard, and leeches must never replace or delay it.
Thumb Carpometacarpal (CMC-1) Osteoarthritis
Off-label use with one small RCT (Michalsen 2008, 32 women) in which single-session leech therapy reduced pain and improved hand function more than topical diclofenac for about 2 months.
Lateral Epicondylitis (Tennis Elbow)
Off-label use with one small RCT (Bäcker 2011, n=40) in which a single leech session reduced pain more than topical diclofenac at day 7; the pain difference was no longer significant at day 45.
References
- [B1]
Баскова И.П., Исаханян Г.С. Гирудотерапия. Наука и практика [Hirudotherapy: Science and Practice]
Monograph in Russian, 506 pp., ISBN 5-89527-058-1. Chapter 15: sensation at the bite, length of the session; secretion kininases and pain.
- [B3]
Michalsen A., Roth M., Dobos G. Medicinal Leech Therapy
ISBN 978-3-13-143581-1 / 978-1-58890-563-5. Chapter 9, p. 107: perceptions of the bite — a local dragging pain lasting around one to five minutes.
The information on this page is based on the hirudotherapy books listed under References and reflects the experience their authors describe. Sensations and results differ from person to person. This information is not medical advice, a diagnosis or a prescription, and it does not replace an examination by a physician. Do not stop or change any prescribed treatment without your physician. Hirudotherapy has contraindications.